Biora Therapeutics, Inc. (BIORQ) vs CDT Equity Inc. (CDT)

Biora Therapeutics, Inc. and CDT Equity Inc. are both Biotechnology companies. Biora Therapeutics, Inc. and CDT Equity Inc. are of similar size ($2.5M and $2.4M). CDT Equity Inc. has the higher net margin (0.00% vs −3,527.9%) and the lower return on invested capital (−21.3% vs 0.00%). Across the 12 metrics below, CDT Equity Inc. leads on 7 and Biora Therapeutics, Inc. on 5.

Valuation

Metric BIORQ CDT Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 67.44 n/m 10.73
Earnings yield 0.00% 167,728,033.38% (28.84%)
Free cash flow yield 0.00% (278,822.70%) (23.03%)

Profitability

Metric BIORQ CDT Biotechnology median
Gross margin 85.79% — 65.16%
Operating margin (6,809.06%) 0.00% 0.00%
Net margin (3,527.85%) 0.00% 0.00%
Free cash flow margin (5,165.88%) 0.00% 0.00%
Return on equity 27.98% (69.68%) (57.72%)
Return on assets (128.19%) (55.16%) (49.22%)
Return on invested capital 0.00% (21.28%) 0.00%

Growth

Metric BIORQ CDT Biotechnology median
Revenue growth (TTM) 347.00% — 5.64%
EPS growth (last fiscal year) (57.40%) 98.09% —
Revenue growth, 5-year CAGR (87.44%) — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BIORQ CDT Biotechnology median
Debt to equity (0.18) 0.00 0.00
Current ratio 0.05 0.13 4.73
Net debt to EBITDA (0.47) 0.05 0.96

Dividend

Metric BIORQ CDT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BIORQ CDT Biotechnology median
Market cap 2.49m 2.41m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack